Journal of
Medicinal Plants Research

  • Abbreviation: J. Med. Plants Res.
  • Language: English
  • ISSN: 1996-0875
  • DOI: 10.5897/JMPR
  • Start Year: 2007
  • Published Articles: 3832

Full Length Research Paper

Immunosuppressive effects of Cucurbitacin B on human peripheral blood lymphocytes

Yaowalak U-pratya1, Usaneeporn Lueangamornnara1, Weena Jiratchariyakul2and Tanawan Kummalue3*
1Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand. 2Department of Pharmacognosy, Faculty of Pharmacy, Mahidol University, Thailand. 3Department of Clinical Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Email: [email protected]

  •  Accepted: 31 August 2010
  •  Published: 18 November 2010

Abstract

This study investigates the immunomodulating effects of cucurbitacin B, a Thai herbal plant; isolated from Trichosanthes cucumerima L., on PHA-stimulated human Peripheral Blood Mononuclear Cells (PBMCs). Stimulated PBMCs were cultured in the presence or absence of cucurbitacin B and then markers of cell activation were measured. The results showed that 0.5 and 0.25 µg/ml of cucurbitacin B significantly inhibited the expression of CD69+CD3+, and CD25+CD3+ whereas no significant inhibition from 0.05 µg/ml of cucurbitacin B was detected. The secretion of TNF-a from stimulated PBMC was significantly inhibited by cucurbitacin B. After 24 h of incubation, the total Cytotoxic Lymphocyte (CTL) activity was significantly reduced by 0.5 µg/ml of cucurbitacin B when compared to the control group (9.83 ± 0.95 and 40.63 ± 2.93, P = 0.0033) or compared with Phytohemagglutinin (PHA) stimulation (9.83 ± 0.95 and 70.09 ± 3.35, P < 0.0001). A similar pattern of CTL activity was found after 48 and 72 h of incubation. In conclusion, cucurbitacin B inhibited PBMC activation by PHA. This study provides evidences that cucurbitacin B could be used as immunosuppressive agent.

 

Key words: Cucurbitacin B, Phytohemagglutinin stimulated peripheral blood mononuclear cell, cytotoxic lymphocyte function, CD69.